Comments*

 
  • Life Sciences & Biomedical Research

  • Events 

    Friday, June 3, 2016 | 8:30 AM - 6:00 PM

    Antibiotics in Food: Can Less Do More?

    Speakers: Seamus Fanning (University College Dublin), Delia Grace (International Livestock Research Institute), William J. Hall (Wellcome Trust), Rebecca Irwin (Public Health Agency of Canada), Francois Malouin (Sherbrooke University), James L. Marsden (Chipotle Mexican Grill), Alan G. Mathew (Purdue University), H. Morgan Scott (Texas A&M University), Stacy E. Sneeringer (USDA), Jaap A. Wagenaar (Utrecht University), and David R. Wolfgang (Pennsylvania State University)

    Antibiotics have been used in human and animal medicine for decades. Reducing the use of antibiotics changes the dynamic between the food supply, food safety, and public health. Food safety practices may emerge a catalyst for change.

    Monday, June 6, 2016 | 1:30 PM - 4:30 PM

    Genome Integrity Discussion Group

    Keynote Speaker: John Diffley (The Francis Crick Institute)

    The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity, and onset and progression of malignancy.

    Monday, June 13, 2016 | 10:00 AM - 3:30 PM

    2016 Ross Prize in Molecular Medicine: Resolution of Inflammation

    Speakers: Ruslan M. Medzhitov (Yale School of Medicine, Howard Hughes Medical Institute), Mauro Perretti (The William Harvey Research Institute, Queen Mary University of London), Charles N. Serhan (Brigham and Women's Hospital & Harvard Medical School), Lars Klareskog (Karolinska Institutet), and Kevin J. Tracey (The Feinstein Institute for Medical Research)

    This symposium will honor Dr. Charles N. Serhan, the recipient of the 2016 Ross Prize in Molecular Medicine, for his important discoveries in identifying bioactive mediators and cellular pathways critical in the resolution of inflammatory diseases.

    Tuesday, June 21, 2016 | 8:00 AM - 5:00 PM

    Surgery and Cognition: Delirium, Cognitive Decline, and Opportunities to Protect the Brain

    Keynote Speaker: Sharon Inouye (Harvard Medical School)

    This meeting will convene leading scientists and physicians to discuss the challenges and opportunities to create biomarkers and therapeutics for these patients who are vulnerable to delirium, cognitive decline, and dementia following surgery.

    Tuesday, June 28, 2016 | 8:00 AM - 5:30 PM

    Multiple Sclerosis: Diagnostic and Treatment Frontiers

    Keynote Speaker: Giancarlo Comi (Universitè Vita-Salute San Raffaele)

    Explore novel and emerging treatments for multiple sclerosis, including biomarkers and MRI usage in disease diagnosis, prognosis, and monitoring.

  • Past Events

    Thursday, May 26, 2016 | 9:00 AM - 6:00 PM

    HIV 2016: HIV and Non-Communicable Diseases — Opportunities and Challenges

    Featured Speaker: Peter Godfrey-Faussett (UNAIDS)

    This event will address the incidence of non-communicable diseases among people living with HIV, describe morbidity and mortality, and explore interactions among HIV, antiretroviral drugs and behavioral factors influencing development and treatment.

    Wednesday, May 25, 2016 | 11:30 AM - 5:00 PM

    Chemical Biology Discussion Group Year-End Symposium

    Speakers: Philip A. Cole (Johns Hopkins University School of Medicine), Kenneth W. Duncan (Epizyme, Inc.)

    The Chemical Biology Discussion Group brings together chemists and biologists interested in discussing the latest breakthroughs. In 2016, the annual year-end meeting features keynote speakers Dr Philip Cole and Dr Kenneth Duncan.

    May 18 - 20, 2016

    The Addicted Brain and New Treatment Frontiers: Sixth Annual Aspen Brain Forum

    Keynote Speakers: Nora D. Volkow (National Institute on Drug Abuse, U.S. National Institutes of Health), George F. Koob (National Institute on Alcohol Abuse and Alcoholism, U.S. National Institutes of Health), and The Honorable Patrick J. Kennedy (Former United States Representative, Rhode Island; Co-Founder, One Mind; and Founder, Kennedy Forum)

    Discover from leading experts, including NIAAA and NIDA directors, the latest on neurobiology of addiction; susceptibility of the teen brain; new treatment strategies; and social, economic, political, and legislative aspects of this disease.

    Wednesday, May 18, 2016 | 5:45 PM - 7:00 PM

    Arrested Development: The Teenage Brain and Substance Abuse

    Moderator: Claudia Wallis (Scientific American Mind)
    Panelists: Jeremy Waletzky (The George Washington University), Nora D. Volkow (NIH), Cheryl Healton (College of Global Public Health, New York University), and Honorable Gregory P. Canova, JD

    1.3 million adolescents in the US have substance use disorder and marijuana use among teens now exceeds cigarette smoking. Join us for a public panel discussion on how neuroscience intersects with policy to improve lives of teens with addiction.

  • Publications 

    eBriefing

    Advances in Human Microbiome Science: Gut–Brain Interaction

    Organizers: John Hambor (Boehringer Ingelheim), Sarkis Mazmanian (California Institute of Technology), Nilufer Seth (Pfizer), Erick Young (Boehringer Ingelheim), Sonya Dougal (The New York Academy of Sciences), and Caitlin McOmish (The New York Academy of Sciences)

    This eBriefing discusses gut–brain interactions and the possibility of targeting the microbiome with a focus on CNS health.

    eBriefing

    Emerging Approaches to Cancer Immunotherapy

    Organizers: Renier Brentjens (Memorial Sloan Kettering Cancer Center), George Zavoico (Jones Trading Institutional Services), Sonya Dougal (The New York Academy of Sciences), and Caitlin McOmish (The New York Academy of Sciences)

    This eBriefing explores advances in cancer immunotherapy, which engages the immune system to detect and destroy cancer cells and has gained popularity and success in recent years.

    eBriefing

    Regenerative Medicine: Transitioning Therapeutics from Cells to the Clinic

    Organizers: Jane S. Lebkowski (Asterias Biotherapeutics), George Zavoico (JonesTrading Institutional Services), Sonya Dougal (The New York Academy of Sciences), and Caitlin McOmish (The New York Academy of Sciences)

    This eBriefing considers efforts to rethink clinical, regulatory, and manufacturing approaches to accelerate the transition of cell-based therapies to the clinic.

    Annals

    Special Issue: Cooley's Anemia

    Edited by Annals of the New York Academy of Sciences editorial staff

    Continuation of over four decades of scientific discussion on Cooley's anemia published in Annals of the New York Academy of Sciences